[Persistent hyperinsulinemic hypoglycemia of the neonate]

Area of Science:

• Pediatric Endocrinology
• Neonatal Medicine
• Medical Genetics

Background:

• Persistent hyperinsulinemic hypoglycemia (PHH) is a rare, heterogeneous neonatal disorder characterized by inappropriately high insulin levels causing severe hypoglycemia.
• This condition presents significant diagnostic and therapeutic challenges, often leading to brain atrophy due to recurrent hypoglycemic episodes.
• PHH has diverse clinical, histological, metabolic, and genetic features, with genetic defects typically located on chromosome 11.

Observation:

• The study focuses on a neonate diagnosed with persistent hyperinsulinemic hypoglycemia.
• The neonate experienced severe hypoglycemia due to inadequately high insulin levels.
• This condition is associated with decreased serum free fatty acids and ketone concentrations, as insulin inhibits lipolysis and ketone body synthesis.

Findings:

• A successful conservative treatment approach was implemented for the affected neonate.
• The treatment successfully managed the persistent hyperinsulinemic hypoglycemia.
• This case demonstrates a viable non-surgical option for managing this rare neonatal condition.

Implications:

• Conservative management can be effective in treating persistent hyperinsulinemic hypoglycemia in neonates.
• Successful treatment can prevent or mitigate long-term complications like brain atrophy.
• Further research into genetic and metabolic pathways may reveal novel therapeutic targets for PHH.